Trials / Completed
CompletedNCT01578304
Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder
Phase IV Study to Evaluate the Efficacy and Safety Imidafenacin Versus Fesoterodine in Patients With Overactive Bladder
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 207 (actual)
- Sponsor
- LG Life Sciences · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety after 12 weeks oral administration of Imidafenacin 0.1mg b.i.d versus Fesoterodine 4mg once daily for the urge incontinence and/or increased urinary frequency associated with urgency as may occur in patients with overactive bladder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Imidafenacin | Tablet, 12 weeks twice daily |
| DRUG | Fesoterodine | Tablet, 12 weeks once daily |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2012-04-16
- Last updated
- 2012-04-16
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01578304. Inclusion in this directory is not an endorsement.